Magnerot (Magnesium Orotate Dihydrate)

After ingestion, magnesium orotate dihydrate releases magnesium ions that act as essential cofactors in many enzymatic processes, including ATP production and ion transport. The orotate component may enhance cellular uptake of magnesium, helping to restore electrolyte balance and support muscle and nerve activity.

The appropriate dose of Magnerot is determined by a qualified healthcare professional based on the patient’s age, clinical condition, serum magnesium level, and any concomitant therapies. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for magnesium orotate dihydrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Magnerot.

To order Magnerot, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Magnerot delivers magnesium bound to orotate, a form that may improve intracellular transport compared with simple magnesium salts such as magnesium oxide. Clinical experience suggests comparable efficacy for correcting deficiency, while some users report better gastrointestinal tolerance, though individual responses can vary.

Store Magnerot at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Magnerot is taken orally, usually with a full glass of water. It can be taken with or without food, but patients who experience gastrointestinal upset may prefer taking it with meals. Follow the dosing schedule prescribed by the healthcare provider.

The most serious risks include hypermagnesemia, which can cause cardiac arrhythmias, severe hypotension, muscle weakness, and, in rare cases, life‑threatening allergic reactions. Patients should seek immediate medical attention if they experience signs such as irregular heartbeat, fainting, or swelling of the face and throat.

Magnerot should be avoided in individuals with known hypersensitivity to magnesium or orotate, and in patients with severe renal impairment where magnesium clearance is compromised. It is also contraindicated in those who have experienced severe allergic reactions to magnesium‑containing products.